Detalhe da pesquisa
1.
The impact of COVID-19 on healthcare booking and cancellation patterns: time series analysis of private healthcare service utilisation in Finland.
BMC Health Serv Res
; 24(1): 483, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38637794
2.
C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients.
Acta Oncol
; 61(10): 1240-1247, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35905053
3.
Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients.
Mod Pathol
; 34(12): 2229-2241, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215851
4.
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
Br J Cancer
; 123(12): 1730-1736, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32989226
5.
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study).
Oncologist
; 24(4): 491-497, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867244
6.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 373(19): 1803-13, 2015 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406148
7.
Cancer costs and outcomes in the Finnish population 2004-2014.
Acta Oncol
; 57(2): 297-303, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28696797
8.
Cancer costs and outcomes for common cancer sites in the Finnish population between 2009-2014.
Acta Oncol
; 57(7): 983-988, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451406
9.
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.
Lancet Oncol
; 17(11): 1590-1598, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733243
10.
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.
Lancet Oncol
; 17(7): 883-895, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27269741
11.
Sunitinib-induced hypertension, neutropaenia and thrombocytopaenia as predictors of good prognosis in patients with metastatic renal cell carcinoma.
BJU Int
; 117(1): 110-7, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25252180
12.
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial.
Lancet Oncol
; 16(16): 1700-10, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26596672
13.
Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial.
Lancet Oncol
; 15(9): 975-85, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24974051
14.
Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma.
Acta Oncol
; 53(1): 113-8, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23721300
15.
Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).
Acta Oncol
; 53(2): 186-94, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23957715
16.
Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments.
Cancer Immunol Res
; 12(1): 48-59, 2024 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922365
17.
[Targeted therapy of a cancer patient is multiprofessional collaboration]. / Syöpäpotilaan täsmähoito on moniammatillista yhteistyötä.
Duodecim
; 129(10): 1071-9, 2013.
Artigo
em Finlandês
| MEDLINE | ID: mdl-23767137
18.
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.
Lancet Oncol
; 13(10): 1055-62, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22959186
19.
Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma.
J Clin Invest
; 133(6)2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719749
20.
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884613